Paul J Pockros
Overview
Explore the profile of Paul J Pockros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
4581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vierling J, Pockros P
Am J Gastroenterol
. 2024 Oct;
120(2):342-343.
PMID: 39356113
No abstract available.
2.
3.
Bowlus C, Eksteen B, Cheung A, Thorburn D, Moylan C, Pockros P, et al.
Hepatol Commun
. 2023 May;
7(6).
PMID: 37184523
Background: Primary sclerosing cholangitis (PSC) is frequently associated with pruritus, which significantly impairs quality of life. Maralixibat is a selective ileal bile acid transporter (IBAT) inhibitor that lowers circulating bile...
4.
Pockros P, Mulgaonkar A
Gastroenterol Hepatol (N Y)
. 2022 Nov;
18(6):320-325.
PMID: 36398137
Most patients treated for chronic hepatitis B infection require lifelong treatment with nucleoside/nucleotide analogues (NAs), which inhibit hepatitis B virus (HBV) replication but do not eradicate the virus or achieve...
5.
Zhang H, Chen F, Giang E, Bao F, Lauer G, Marsh C, et al.
Antivir Ther
. 2022 Apr;
26(1-2):3-8.
PMID: 35485347
Nucleos(t)ide analogues (NAs) are a mainstay of therapy for chronic hepatitis B (CHB) infections and have a profound effect on hepatitis B virus (HBV) suppression. We report a rare case...
6.
Eksteen B, Bowlus C, Montano-Loza A, Lefebvre E, Fischer L, Vig P, et al.
Hepatol Commun
. 2021 Mar;
5(3):478-490.
PMID: 33681680
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease with no approved treatments. C-C chemokine receptor types 2 and 5 (CCR2/CCR5) play an important role in inflammation and fibrosis and...
7.
Dieterich D, Bernstein D, Flamm S, Pockros P, Reau N
Aliment Pharmacol Ther
. 2020 Aug;
52(8):1311-1322.
PMID: 32813292
Background: Thrombocytopenia is the most common haematological abnormality in patients with chronic liver disease in the United States. Severe thrombocytopenia (platelet count <50 × 10 /L) can complicate the management...
8.
Pockros P
Gastroenterol Hepatol (N Y)
. 2019 Dec;
15(11):616-618.
PMID: 31802987
No abstract available.
9.
10.
Bowlus C, Pockros P, Kremer A, Pares A, Forman L, Drenth J, et al.
Clin Gastroenterol Hepatol
. 2019 Oct;
18(5):1170-1178.e6.
PMID: 31606455
Background & Aims: Primary biliary cholangitis (PBC) is an autoimmune disease characterized by bile duct destruction that can progress to cirrhosis. A liver biopsy substudy was conducted in the PBC...